Patient characteristics in relation to opioid exposure in a chronic non-cancer pain population

  • 0Department of Clinical Sciences Malmö, Center for Primary Health Care Research, Lund University, Jan Waldenströms Gata 35, 202 13 Malmö, Sweden.

|

|

Summary

This summary is machine-generated.

Long-term opioid therapy (LTOT) for chronic non-cancer pain (CnCP) is linked to higher opioid doses and increased risks. Benzodiazepine use and male sex are associated with LTOT and higher opioid dosages, indicating potential safety concerns.

Area Of Science

  • Pain Medicine
  • Pharmacology
  • Public Health

Background

  • Long-term opioid therapy (LTOT) for chronic non-cancer pain (CnCP) presents questionable efficacy and established risks.
  • Understanding patient characteristics associated with LTOT and high opioid dosages is crucial for risk mitigation.
  • Opioid use disorder and overdose risks necessitate careful evaluation of treatment patterns.

Purpose Of The Study

  • To compare characteristics of patients on LTOT versus those not exposed.
  • To identify risk factors for opioid use disorder or overdose among opioid-exposed patients, particularly in relation to dosage.
  • To analyze the influence of LTOT on opioid dosage and associated comorbidities.

Main Methods

  • Cross-sectional study of 1,604 adult CnCP patients from a Swedish tertiary pain rehabilitation clinic (2018-2020).
  • Data linkage with the Swedish Prescribed Drug Register for dispensed opioid information.
  • Analysis of LTOT status and opioid dosage (mg morphine equivalent/day [MME/day]), comparing <50 MME/day vs. ≥50 MME/day.

Main Results

  • 26.4% of patients received LTOT; 89 patients had dosages ≥50 MME/day.
  • LTOT was associated with increased odds of benzodiazepine use (OR 2.685) and male sex (OR 1.694).
  • Patients with opioid doses ≥50 MME/day were predominantly on LTOT and showed higher odds of benzodiazepine use and male sex.

Conclusions

  • Long-term opioid therapy significantly influences prescribed opioid dosage.
  • Concomitant benzodiazepine use and male sex are over-represented in patients on LTOT and those with high opioid doses (≥50 MME/day).
  • These findings highlight key factors associated with higher-risk opioid prescribing in chronic pain management.

Related Concept Videos

Analgesia and Pain Management 01:25

496

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...

Opioid Analgesics: Morphine and Other Natural Cogeners 01:20

179

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...

Opioid Analgesics: Synthetic and Semisynthetic Opioids 01:15

219

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...

Opioid Receptors: Overview 01:22

510

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...

Nociception 01:44

27.7K

Nociception—the ability to feel pain—is essential for an organism’s survival and overall well-being. Noxious stimuli such as piercing pain from a sharp object, heat from an open flame, or contact with corrosive chemicals are first detected by sensory receptors, called nociceptors, located on nerve endings. Nociceptors express ion channels that convert noxious stimuli into electrical signals. When these signals reach the brain via sensory neurons, they are perceived as pain.

Prescription, Nonprescription and Orphan Drugs 01:02

687

Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...